Showing results (511-520 of 536) with videos related to
Sort By:
Pageof 54
Journal of Hypertension|March 14, 2007
Renal function and risk for cardiovascular events in type 2 diabetic patients with hypertension: the RENAAL and LIFE studiesWouter B A Eijkelkamp, Zhongxin Zhang, Barry M Brenner, et al.Circulation|December 28, 2018
Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINADarren K McGuire, John H Alexander, Odd Erik Johansen, et al.Diabetes Care|May 24, 2020
Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized TrialVlado Perkovic, Robert Toto, Mark E Cooper, et al.Diabetes|May 31, 2008
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetesAino Soro-Paavonen, Anna M D Watson, Jiaze Li, et al.Advanced Materials (Deerfield Beach, Fla.)|March 13, 2023
An Engineered Nanosugar Enables Rapid and Sustained Glucose-Responsive Insulin Delivery in Diabetic MiceRong Xu, Sukhvir Kaur Bhangu, Karly C Sourris, et al.Diabetes|May 11, 2017
Protective Effect of let-7 miRNA Family in Regulating Inflammation in Diabetes-Associated AtherosclerosisEoin Brennan, Bo Wang, Aaron McClelland, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 14, 2021
Apoptotic Ablation of Platelets Reduces Atherosclerosis in Mice With DiabetesMan K S Lee, Michael J Kraakman, Dragana Dragoljevic, et al.JAMA|November 13, 2018
Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical TrialJulio Rosenstock, Vlado Perkovic, Odd Erik Johansen, et al.Diabetes|March 11, 2022
Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-Sensitive PathwaysJay C Jha, Aozhi Dai, Jessica Garzarella, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 11, 2017
ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKDDavid M Charytan, Scott D Solomon, Peter Ivanovich, et al.Pageof 54